Your browser doesn't support javascript.
loading
تبين: 20 | 50 | 100
النتائج 1 - 7 de 7
المحددات
إضافة المرشحات








النطاق السنوي
1.
Rev. Nutr. (Online) ; 35: e200148, 2022. tab
مقالة ي الانجليزية | LILACS | ID: biblio-1360809

الملخص

ABSTRACT Objective Dietary supplements use is increasing. Dietary supplements may contain high doses of substances or dangerous ingredient combinations. This article aims to investigate, by analyzing dietary supplements labels, if there are any doping substances or dangerous amounts of any other component in the reviewed dietary supplements. Methods Several brands which possessed their supplements sorted in pre-workout and post-workout were analyzed. 40 dietary supplements with all ingredients described were included. The minimum and maximum dosages of dietary supplements were statistically described as Mean±SD. Results Citrus aurantium extract, Yohimbe extract, Garcinia cambogia extract and Maca root extract were reported in some of the analyzed dietary supplements. Regarding caffeine, the pre-workout group displayed higher mean caffeine (241±86mg) than the post-workout group (183±68mg), and the minimal mean dose was 226±84mg; meanwhile, the maximal mean dose was 242±88mg. Concerning creatine, the pre-workout group displayed lower mean creatine (3106±1079mg) than the post-workout group (4137±4177mg), and the minimal mean dose was 3167±1728mg; meanwhile, the maximal mean dose was 3917±3643mg. The salt content in the post-workout group displayed a much higher mean (2155±4486mg) than the pre-workout group (464±605mg), and the minimal mean dose was 1635±3930mg; meanwhile, the maximal mean dose was 1708±3926g. Conclusions No doping substances were reported in the dietary supplements, but consumption recommendations on the label could lead to excessive consumption of some not yet fully tested ingredients.


RESUMO Objetivo O uso de suplementos alimentares está a aumentar. Estes podem conter altas doses de substâncias ou combinações de ingredientes perigosas. Este artigo procura encontrar, analisando os rótulos dos produtos, se existem substâncias dopantes ou nocivas. Métodos Foram analisadas várias marcas cujos respectivos suplementos foram classificados em pré e pós-treino. Foram incluídos 40 suplementos com todos os ingredientes descritos. A respectiva dose mínima e máxima foi descrita estatisticamente como média ± DP. Resultados Extratos de Citrus aurantium, Yohimbe, Garcinia cambogia e raiz de Maca foram encontrados nos suplementos analisados. O grupo pré-treino apresentou maior média de cafeína (241±86mg) do que o grupo pós-treino (183±68mg), e a dose média mínima foi de 226±84mg, enquanto a dose média máxima foi de 242±88 mg. O grupo pré-treino apresentou menor média de creatina (3106±1079mg) do que o grupo pós-treino (4137±4177mg), e a dose média mínima foi de 3167±1728mg, enquanto a dose média máxima foi de 3917±3643mg. O grupo pós-treino apresentou uma maior média de sal (2155±4486mg) do que o grupo pré-treino (464±605mg), e a dose média mínima foi 1635±3930mg, enquanto a dose média máxima foi de 1708±3926mg. Conclusão Não foram encontradas substâncias dopantes nos suplementos, mas algumas recomendações de consumo nos rótulos poderão levar à sobredose de certos ingredientes menos testados.


الموضوعات
Dietary Supplements/analysis , Dietary Supplements/toxicity , Dosage , Performance-Enhancing Substances , Risk Assessment
2.
J. bras. nefrol ; 42(2): 238-244, Apr.-June 2020. graf
مقالة ي الانجليزية, البرتغالية | LILACS | ID: biblio-1134823

الملخص

Abstract Fortification of food products with vitamin D was central to the eradication of rickets in the early parts of the 20th century in the United States. In the subsequent almost 100 years since, accumulating evidence has linked vitamin D deficiency to a variety of outcomes, and this has paralleled greater public interest and awareness of the health benefits of vitamin D. Supplements containing vitamin D are now widely available in both industrialized and developing countries, and many are in the form of unregulated formulations sold to the public with little guidance for safe administration. Together, this has contributed to a transition whereby a dramatic global increase in cases of vitamin D toxicity has been reported. Clinicians are now faced with the challenge of managing this condition that can present on a spectrum from asymptomatic to acute life-threatening complications. This article considers contemporary data on vitamin D toxicity, and diagnostic and management strategies relevant to clinical practice.


Resumo A suplementação de produtos alimentares com vitamina D foi fundamental para a erradicação do raquitismo no início do século XX nos Estados Unidos. Nos quase 100 anos subsequentes, o acúmulo de evidências vinculou a deficiência de vitamina D a uma variedade de desfechos, e isso tem levantado grande interesse público e conscientização dos benefícios à saúde da vitamina D. Os suplementos que contêm vitamina D estão agora amplamente disponíveis tanto nos países desenvolvidos quanto naqueles em desenvolvimento, e muitos estão na forma de formulações não regulamentadas, vendidas ao público com poucas orientações para uma administração segura. Juntos, isso contribuiu para uma transição na qual um aumento global dramático nos casos de toxicidade da vitamina D tem sido relatado. Médicos agora enfrentam o desafio de tratar essa condição que pode apresentar um espectro de complicações assintomáticas a agudas, com risco de vida. Este artigo considera dados atualizados sobre a toxicidade da vitamina D e estratégias de diagnóstico e manejo relevantes para a prática clínica.


الموضوعات
Humans , Male , Aged , Rickets/prevention & control , Vitamin D/toxicity , Dietary Supplements/toxicity , Acute Kidney Injury/chemically induced , Rickets/epidemiology , Vitamin D Deficiency/complications , Vitamin D Deficiency/drug therapy , Treatment Outcome , Dietary Supplements/supply & distribution , Withholding Treatment , Acute Kidney Injury/therapy , Hypercalcemia/complications , Hypercalcemia/diagnosis , Hypercalcemia/chemically induced , Hypercalcemia/therapy
3.
Acta cir. bras ; Acta cir. bras;30(5): 313-318, 05/2015. tab, graf
مقالة ي الانجليزية | LILACS | ID: lil-747024

الملخص

PURPOSE: To evaluate the renal and hepatic function, through biochemical analysis after 14 days of creatine supplementation in physically inactive rats. METHODS: Twenty four male, adult, Wistar rats were used which were kept in individual metabolic cages and were distributed into four groups, and received the following treatments by gavage:1) Control: distilled water; 2)Creatine 0.5g/Kg/day; 3) Creatine 1g/Kg/day; 4) Creatine 2g/Kg/day. Their urinary outputs as well as food and water intake were daily measured. At the end of the experiment, the animals were euthanized and serum samples were stored for biochemical analysis. RESULTS: Creatine supplementation at the doses given produced no significant changes in plasma levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total protein, albumin, total cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol, triglycerides, glucose, creatinine, urea, and creatinine clearance, compared to control group (p> 0.05) Similarly, water and food intake, as well as urinary output, did not show significant changes among the four groups studied. CONCLUSION: At the doses used, oral creatine supplementation did not result in renal and/or hepatic toxicity. .


الموضوعات
Animals , Male , Creatine/administration & dosage , Creatine/toxicity , Dietary Supplements/toxicity , Kidney/drug effects , Liver/drug effects , Alanine Transaminase/blood , Albumins/analysis , Alkaline Phosphatase/blood , Aspartate Aminotransferases/blood , Blood Glucose/analysis , Cholesterol/blood , Creatine/analysis , Creatinine/blood , Kidney/metabolism , Liver/metabolism , Random Allocation , Rats, Wistar , Reference Values , Time Factors , Triglycerides/blood , Urea/blood
4.
Rev. méd. Chile ; 134(1): 95-100, ene. 2006.
مقالة ي الأسبانية | LILACS | ID: lil-426125

الملخص

The frequency of Crohn disease shows a significant increase in the last century. Affected patients show a misbalance between production of free radicals and anti oxidant defenses. Thus, one of the increasingly accepted htypotheses to explain the origin of this disease, is the oxidative stress that occurs in the intestinal mucosa. Dietary factors including self administered vitamin and mineral supplemets may play a role, especially when they contain excessive amounts of iron and copper, known for their prooxidant capacities. Unfortunately, little is known about how these metals may influence the antioxidant defenses in the intestinal mucosa. This article reviews the literature on the why and how these elements may act on individuals susceptible to develop Crohm disease, including the evidence supporting the hypothesis that oxidative stress in the intestinal mucosa is an important pathogenetic factor.


الموضوعات
Humans , Crohn Disease/etiology , Intestinal Mucosa/metabolism , Oxidative Stress/physiology , Reactive Oxygen Species/metabolism , Copper/toxicity , Crohn Disease/metabolism , Dietary Supplements/toxicity , Iron/toxicity
6.
Indian J Exp Biol ; 2001 Oct; 39(10): 1068-70
مقالة ي الانجليزية | IMSEAR | ID: sea-57959

الملخص

Pretreatment of aqueous extracts of Zyrulina (Spirulina), Aswagandha (Withania) and Nopane (Boswellia) on colchicine induced chromosome damage showed weakness of clastogenic activity in Swiss albino mice. None of the treatments increased significantly the number of chromosome aberrations.


الموضوعات
Eukaryota/chemistry , Animals , Bacterial Proteins/chemistry , Boswellia/chemistry , Chromosome Aberrations/drug effects , Dietary Supplements/toxicity , Mice , Mutagenesis/drug effects , Mutagenicity Tests , Mutagens/isolation & purification , Plant Extracts/isolation & purification , Plants, Medicinal/toxicity , Spirulina
7.
Indian J Exp Biol ; 2001 May; 39(5): 441-6
مقالة ي الانجليزية | IMSEAR | ID: sea-59376

الملخص

Lactulose has profound health benefits by way of increasing bifidobacterial flora in the intestine of infants thereby protecting them against enteric infection, constipation and systemic encephalopathy. In the present study to assess the sub chronic toxicity of lactulose syrup, the rats were fed on a basal feed supplemented with lactulose syrup at 0.5, 1.0, 2.0 and 5.0% for a period of 21 weeks. Monitoring of food consumption, gain in body weight and physical observations did not reveal any treatment-related toxicity in any of the group of rats. Terminal autopsy also did not reveal any signs of toxicity. Further, no significant alterations in relative organ weight, serum biochemistry and urinalysis were observed up to 1% lactulose supplementation level. The results suggest that supplementation of lactulose in the diet does not produce any toxicity at the doses tested.


الموضوعات
Administration, Oral , Animals , Blood Cell Count , Blood Chemical Analysis , Dietary Supplements/toxicity , Dose-Response Relationship, Drug , Lactulose/administration & dosage , Male , Organ Size/drug effects , Rats , Rats, Wistar , Safety , Weight Gain/drug effects
اختيار الاستشهادات
تفاصيل البحث